A randomized study of lapatinib alone or in combination with trastuzumab in heavily pretreated HER2+ metastatic breast cancer progressing on trastuzumab therapy

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 26; no. 15_suppl; p. 1015
Main Authors O'Shaughnessy, J., Blackwell, K. L., Burstein, H., Storniolo, A. M., Sledge, G., Baselga, J., Koehler, M., Laabs, S., Florance, A., Roychowdhury, D.
Format Journal Article
LanguageEnglish
Published 20.05.2008
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2008.26.15_suppl.1015